SFA THERAPEUTICS
SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs.
SFA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Jenkintown, Pennsylvania, United States
Country:
United States
Website Url:
http://www.sfatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
1-267-584-1080
Total Funding:
4.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Artielle ImmunoTherapeutics
Artielle ImmunoTherapeutics develops recombinant T-cell receptor ligands to treat T-cell-mediated inflammatory diseases.
Atomo Coffee
Atomo Coffee is a developer of molecular coffee.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Beta Therapeutics
Beta Therapeutics provides service for medical research.
Carmot Therapeutics
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.
Elgia Therapeutics
Elgia Therapeutics is a biopharmaceutical company.
Enterprise Therapeutics
A UK-based developer of drugs to treat respiratory diseases
EOS Remediation
EOS Remediation is a developer of products that treat contaminated soil and groundwater.
ERAD Therapeutics
ERAD Therapeutics is a developer of a drug platform designed to create novel biological agents to treat orphan diseases
GT Apeiron Therapeutics
GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology.
Nitrase Therapeutics
Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).
Odyssey Therapeutics
Odyssey Therapeutics provides medicines to patients with inflammatory diseases and cancer.
Orbus Therapeutics
Orbus Therapeutics is dedicated to developing products that treat rare diseases.
Recludix Pharma
Recludix pharma is a developing platform to treat cancer patients.
scibac
SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
SynAct Pharma
SynAct Pharma develops drugs for acute deterioration in inflammatory diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Robert Dickey Chief Financial Officer @ SFA Therapeutics
Chief Financial Officer
2021-12-01
Alla Arzumanyan CDO and Co-Founder @ SFA Therapeutics
CDO and Co-Founder
2017-01-01
Ira Spector CEO @ SFA Therapeutics
CEO
2017-08-01
Mark Feitelson CSO and Co-Founder @ SFA Therapeutics
CSO and Co-Founder
Founder
Investors List
Boost VC
Boost VC investment in Seed Round - SFA Therapeutics
Acequia Capital (AceCap)
Acequia Capital (AceCap) investment in Seed Round - SFA Therapeutics
INP Capital
INP Capital investment in Seed Round - SFA Therapeutics
North South Ventures
North South Ventures investment in Seed Round - SFA Therapeutics
Savantus Ventures
Savantus Ventures investment in Seed Round - SFA Therapeutics
Asymmetry Ventures
Asymmetry Ventures investment in Seed Round - SFA Therapeutics
Reinforced Ventures
Reinforced Ventures investment in Seed Round - SFA Therapeutics
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Grant - SFA Therapeutics
Official Site Inspections
http://www.sfatherapeutics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "SFA Therapeutics"
SFA Therapeutics - Crunchbase Company Profile
Contact Email ira.spector.sfatherapeutics@gmail.com Phone Number 1-267-584-1080 SFA Therapeutics is a development-stage bio-pharmaceutical startup …See details»
SFA Therapeutics, Inc. Receives an FDA Orphan Drug Designation …
While hepatocellular carcinoma afflicts 54,000 patients a year in the US (Cancer.net), the World Health Organization estimates the disease causes as many as 880,000 deaths per year …See details»
SFA Therapeutics Company Profile | Management and Employees …
Www.sfatherapeutics.com SFA Therapeutics Profile and History SFA Therapeutics, Inc. is a bio-pharmaceutical company focused on new human-microbiome-based advancements in the …See details»
SFA Therapeutics (USA) Funding: $8.6M
3 days ago SFA Therapeutics, LLC is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as...See details»
SFA Therapeutics Strengthens Management Team with …
Jul 16, 2024 Mr. Kirwin is a seasoned biopharmaceutical clinical operations leader with over 20 years of experience in directing research and innovation at global pharmaceutical companies …See details»
SFA Therapeutics - VentureRadar
Website: https://www.sfatherapeutics.com/ Develops microbiome-derived drugs to treat chronic inflammatory diseases, providing safer alternatives to current therapies.See details»
SFA Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for SFA Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
SFA Therapeutics - 2025 Company Profile - Tracxn
Mar 7, 2025 SFA Therapeutics - Developer of microbiome-derived therapeutics for the treatment of inflammatory diseases. Raised a total funding of $4.12M over 3 rounds from 12 investors. …See details»
Drug pipelines, Patents, Clinical trials - Synapse - Patsnap
Www.sfatherapeutics.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The …See details»
SFA Therapeutics - LinkedIn
SFA Therapeutics is a clinical stage start-up biotech company developing compounds discovered in human microbiome. This patented and proprietary platform is based on immuno-modulation of ...See details»
SFA Therapeutics Company Information - Funding, Investors, and …
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
SFA Therapeutics - Craft
SFA Therapeutics is a biopharmaceutical company specializing in the treatment of chronic inflammatory disease. The company develops a platform that is based on immuno-modulation …See details»
SFA Therapeutics - Ben Franklin Technology Partners
Iraspector@sfatherapeutics.com. Dr. Ira C. Spector CEO. Dr. Mark Feitelson CSO. Dr. Alla Arzumanyan CDO. Mr. James Kirwin COO. Dr. King Lee VP Regulatory Affairs. Ben Franklin …See details»
SFA Therapeutics Strengthens Management Team with …
JENKINTOWN, Pa., May 2, 2024 /PRNewswire/ -- SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for the …See details»
SFA Therapeutics - Overview, News & Similar companies - ZoomInfo
Jan 3, 2023 SFA Therapeutics Announces FDA Clearance for Amendment to Extend Phase 1b Trial of SFA-002 for Psoriasis JENKINTOWN, Pa., Jan. 11, 2023 /PRNewswire/ -- SFA …See details»
SFA Therapeutics, Inc. Requests FDA Orphan Drug Designation …
Aug 5, 2019 While hepatocellular carcinoma afflicts 54,000 patients per year in the US (Cancer.net), the World Health Organization estimates the disease causes as many as …See details»
SFA Therapeutics Selected as 2021 Company and Pitch …
SFA Therapeutics Selected as 2021 Company and Pitch Presentation Award Honoree at 11th Annual BioPartnering ConferenceSee details»
Theratechnologies Receives FDA Approval for EGRIFTA WR™ …
New, improved formulation set to replace EGRIFTA SV ®. MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) …See details»
SFA Therapeutics Ranked Most Fundable Company by Pepperdine …
To learn more about SFA Therapeutics, please visit www.sfatherapeutics.com.To learn more about the Most Fundable Companies initiative, visit the Pepperdine Graziadio website. SFA …See details»
Foundation S: Creating Healthier Futures - Sanofi
To realize these ambitions, Foundation S – The Sanofi Collective is structured as follows: The Foundation’s “Think Tank” brings together the best minds to channel societal expectations and …See details»